InvestDashboard.com



Agile Therapeutics, Inc. (AGRX)



$1.82
52 Week Low
$3.59
2017-04-28 15:01:58 MDT
$8.65
52 Week High

Basic Info

Healthcare
Sector
Drugs - Generic
Industry
Nasdaq
Stock Exchange
United States
Country

Market Cap: $88,630,000Micro Cap (Less than $200M)
Analyst Recommendation:1.5Analysts say: Strong Buy. (1=Strong Buy, 5=Strong Sell)
Beta: N/A Unknown Beta. A beta of 1 means that stock will go up or down at the same rate as the S&P 500 index.

Fundamentals

ForwardPE: Unknown
5 Yr Est Growth: Unknown
Yield: 0.00%
PEG-Y Ratio: N/A
Unknown PEG-Y ratio

Technicals

% Above 50 DayMA: 27.76%
% Above 200 DayMA: -21.62%
AGRX Performance 52 Weeks: -50.08%
S&P 500 Performance 52 Weeks: 12.50%
Mixed Trend. Short Term trend is up, but longer term trend is down. Currently beyond technical death cross because 50 Day MA is below 200 Day MA. Stock is closer to 52 Week Low than 52 Week High.
AGRX underperforming S&P 500 by -62.58% the last 52 Weeks.

Profile


More Valuation

Price To Book: 2.06
Great Value. Low Price to Book means better value.
EV to EBITDA: -1.83
Unknown EV to EBITDA ratio

More Info

Field Value Average Comments
% Held By Insiders13.89% 17.28%Held by fewer than average Insiders.
% Held By Institutions77.00% 62.07%Institutional percentage greater than average. Institutional buying and selling can really move stock price.
Short % Of Float7.18% 07.02% Shorted by greater than average percent. Investors and traders do not believe in stock. But watch out for short squeezes pushing stock upwards.
Debt to Equity0.38 1.08 More Conservative Financing. Each industry has different Debt/Equity standard. Higher than 1 means company is taking on more leverage.
Profit Margin %N/A-00.18%Unknown.
Operating Margin %N/A-05.28%Unknown.
Return on Equity %-79.80%-08.79% Return on Equity less than average percent. Stock can do better than this?
Return on Assets %-32.51%-01.29% Return on Assets less than average percent. Stock can do better than this?
Revenue Per Employee $N/A $883,096.70Unknown.
Price to Cash 2.12 5.52 Lower than average Price to Cash. Meaning that the company has a higher percentage of cash as a percent of price. Cash can be good to cushion company during hard times, and as a potential source for buyouts or investments. However, some activists want the cash to be used by a company to buy its own stock, or to increase their dividend, or to invest the money.
CPEGY Ratio N/A 2.26Unknown.

Quick Thoughts

PROS:
  1. Analysts like this stock: 1.5 (1=Strong Buy, 5=Strong Sell)

  2. Stock is Above Short Term 50DMA: 27.76%

  3. Price to Cash Ratio (2.12) is less than average. Good. Company has more cash as percentage of price than other companies.

  4. Price to Book is under 5: 2.06

  5. Debt To Equity is lower than 1: 0.38

CONS:
  1. Stock is Below Long Term 200DMA: -21.62%

  2. Stock underperforming S&P 500 over last 52 weeks: -62.58%

  3. Shorted more than average: 7.18%

  4. Return on Equity is negative: -79.80%

  5. Return on Assets is negative: -32.51%


Headlines


Stock Chart


InvestDashboard.com AGRX: Agile Therapeutics, Inc.

This page updated Thu Feb 1 22:00:01 MST 2018.